- Epratuzumab
drugbox
type = mab
source = Humanized
target =CD22
CAS_number =
ATC_prefix =
ATC_suffix =
PubChem =
DrugBank =
chemical_formula =
molecular_weight =
bioavailability =
protein_bound =
metabolism =
elimination_half-life =
excretion =
pregnancy_AU =
pregnancy_US =
pregnancy_category=
legal_AU =
legal_CA =
legal_UK =
legal_US =
legal_status =
routes_of_administration =Epratuzumab is a
humanize dmonoclonal antibody . Potential uses may be found inoncology and in treatment of inflammatoryautoimmune disorder s, such as lupus (SLE).See also
*
Biotechnology
*Immunology
*Oncology External links
* [http://clincancerres.aacrjournals.org/cgi/content/full/9/10/3982S Epratuzumab, a humanized monoclonal antibody targeting CD22: characterization of in vitro properties] Clinical Cancer Research Vol. 9, September 1, 2003 "free full text"
* [http://clincancerres.aacrjournals.org/cgi/content/full/11/14/5215 Dose-Fractionated Radioimmunotherapy in Non-Hodgkin's Lymphoma Using DOTA-Conjugated, 90Y-Radiolabeled, Humanized Anti-CD22 Monoclonal Antibody, Epratuzumab] Clinical Cancer Research Vol. 11, July 15, 2005 "free full text"
Wikimedia Foundation. 2010.